Skip to main content
logo
Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
12.86
-0.27 (-2.06%)
At close: Aug 24, 2026, 4:00 PM EDT
13.07
+0.21 (1.63%)
Pre-market: Aug 25, 2026, 8:02 AM EDT

Candel Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----0.130.13
Revenue Growth
----0%0%
Gross Profit
-----20.22-14.47
Operating Income
-71.98-48.18-33.33-38-34.72-25.73
Net Income
-88.53-38.18-55.18-37.94-18.79-36.12
Earnings Per Share
-1.44-0.72-1.74-1.31-0.65-1.91
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
201.57119.73102.6535.4170.0682.64
Total Debt
49.5249.0313.4722.7622.80.56
Net Cash (Debt)
152.0570.789.1812.6547.2682.08
Net Cash Growth
64.65%-20.73%604.95%-73.23%-42.43%140.66%
Net Cash Per Share
2.471.332.820.441.644.35

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-56.02-38.31-27.02-34.24-31.42-22.22
Capital Expenditures
-1.3-0.59-0.02-0.46-1.3-1.84
Free Cash Flow
-57.32-38.9-27.04-34.7-32.72-24.05
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
-----27777.60%-20580.80%
Pretax Margin
-----15035.20%-28899.20%
Profit Margin
-----15035.20%-28899.20%
FCF Margin
-----26172.80%-19242.40%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----413.761794.84